Jun 4, 2025 07:00AM
Jun 4, 2025 07:00AM
May 21, 2025 07:23PM
May 7, 2025 07:00AM
Apr 2, 2025 07:01AM
Apr 2, 2025 07:00AM
Mar 17, 2025 06:40AM Vigil Neuroscience Inc (VIGL) PT Lowered to $14 at H.C. Wainwright
Mar 13, 2025 10:03AM
Mar 13, 2025 07:00AM
Jan 23, 2025 07:00AM
Jan 23, 2025 07:00AM
Jan 8, 2025 04:05PM
Nov 7, 2024 07:00AM
Sep 19, 2024 06:54AM Mizuho Reiterates Outperform Rating on Vigil Neuroscience Inc (VIGL)
Sep 17, 2024 07:00AM
Sep 17, 2024 07:00AM
Aug 15, 2024 07:56AM
Aug 13, 2024 07:00AM
Jul 30, 2024 04:05PM
Jul 30, 2024 04:05PM
Jul 24, 2024 07:00AM Vigil Neuroscience (VIGL) Reports Interim Data from Ongoing Phase 1 Clinical Trial of VG-3927
Jul 24, 2024 07:00AM
Jul 19, 2024 06:06AM
Jul 18, 2024 02:37PM
Jul 18, 2024 07:01AM
Jul 18, 2024 07:00AM
Jun 27, 2024 05:40AM
Jun 27, 2024 02:00AM Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
May 7, 2024 04:05PM
Apr 17, 2024 04:05PM
Apr 17, 2024 04:05PM
Mar 26, 2024 07:05AM
Mar 6, 2024 04:25PM
Mar 6, 2024 04:25PM
Jan 3, 2024 04:31PM Vigil Neuroscience (VIGL) Issues 2023 Update, Highlights 2024 Milestones
Jan 3, 2024 04:30PM
Nov 16, 2023 04:05PM
Nov 16, 2023 04:05PM
Nov 7, 2023 07:05AM
Oct 17, 2023 07:05AM
Sep 26, 2023 07:05AM
Sep 26, 2023 07:05AM Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP
Sep 8, 2023 04:05PM
Aug 8, 2023 07:05AM
Aug 8, 2023 07:05AM
Aug 7, 2023 04:05PM
May 10, 2023 07:00AM
May 9, 2023 07:01AM
May 9, 2023 07:00AM Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors
Mar 30, 2023 04:12PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All